BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ·Healthcare·Biotechnology
$8.15
-1.87%
Mkt Cap $2.53B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (15 analysts)
$20.00
Range $14.00 – $29.00
Implied Upside
+145.5%
Consensus $20.00 vs current $8.15
NASDAQ·Healthcare·Biotechnology
$8.15
-1.87%
Mkt Cap $2.53B
Buy
8
Hold
0
Sell
0
Price Target (15 analysts)
$20.00
Range $14.00 – $29.00
+145.5%
Consensus $20.00 vs current $8.15